Legend Biotech Corporation (ADR)
General ticker "LEGN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $3.2B (TTM average)
Legend Biotech Corporation (ADR) follows the US Stock Market performance with the rate: 5.3%.
Estimated limits based on current volatility of 2.3%: low 26.97$, high 28.25$
Factors to consider:
- Total employees count: 882 as of 2020
- Current price 19.7% below estimated low
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [41.18$, 82.71$]
- 2024-12-30 to 2025-12-30 estimated range: [34.62$, 71.20$]
Short-term LEGN quotes
Long-term LEGN plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $117.00MM | $285.14MM | $627.24MM |
| Operating Expenses | $572.62MM | $724.63MM | $930.48MM |
| Operating Income | $-455.62MM | $-439.49MM | $-303.24MM |
| Non-Operating Income | $9.90MM | $-80.63MM | $145.11MM |
| Interest Expense | $10.80MM | $21.79MM | $21.61MM |
| R&D Expense | $335.65MM | $382.22MM | $413.54MM |
| Income(Loss) | $-445.72MM | $-520.12MM | $-158.13MM |
| Profit(Loss)* | $-446.35MM | $-518.25MM | $-177.03MM |
| Stockholders Equity | $744.31MM | $1,251.37MM | $1,040.55MM |
| Inventory | $10.35MM | $19.43MM | $23.90MM |
| Assets | $1,330.96MM | $1,848.61MM | $1,670.15MM |
| Operating Cash Flow | $-201.28MM | $-393.28MM | $-144.03MM |
| Capital expenditure | $22.27MM | $22.72MM | $14.11MM |
| Investing Cash Flow | $-77.09MM | $92.79MM | $-850.54MM |
| Financing Cash Flow | $377.98MM | $791.49MM | $5.70MM |
| Earnings Per Share** | $-5.61 | $-5.89 | $-1.94 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.